The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Importance Thrombolytic therapy may be beneficial in the treatment of some patients with
pulmonary embolism. To date, no analysis has had adequate statistical power to determine …

Background We investigated whether right ventricular dysfunction (RVD) as assessed by
echocardiogram can be used as a prognostic factor in hemodynamically stable patients with …

Venous thrombo-embolism is the third most frequent acute cardiovascular syndrome after
myocardial infarction and stroke. Recently published landmark trials paved the way for …

The optimal N-terminal pro-brain natriuretic peptide (NT-proBNP) cut-off value for risk
stratification of pulmonary embolism remains controversial. In this study we validated and …

Background The efficacy of thrombolytic therapy in patients with submassive pulmonary
embolism (PE) remains unclear. Previous meta‐analyses have not separately reported the …

BACKGROUND Patent foramen ovale (PFO) in pulmonary embolism (PE) is associated with
an increased risk of complications. However, little is known about PFO and ischemic stroke …

Introduction The role of thrombolysis in hemodynamically stable patients with acute
pulmonary embolism (PE) remains controversial. We performed a meta-analysis of …

Background Patent foramen ovale (PFO) is an established risk factor for ischemic stroke.
Since acute right ventricular dysfunction (RVD) observed in patients with PE can lead to right …

Study Objective To identify risk factors associated with bleeding in patients who received
alteplase for pulmonary embolism (PE), with a specific focus on risk factors available to the …